Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 1, 2009, Pages 79-83

  Oliviero, Francesca ^a   Sfriso, Paolo ^a   Baldo, Goretta ^a   Dayer, Jean Michael ^b   Guinco, Silvia ^a   Scanu, Anna ^a   Bernardi, Daniela ^a   Ramonda, Roberta ^a   Plebani, Mario ^a   Punzi, Leonardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Apolipoproteins; Arthritis; Cytokines; Inflammation; Synovial fluid

Indexed keywords

APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

EID: 63049103938     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. VAN DOORNUM S, MCCOLL GA WICKS IP: Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002; 46: 862-73.
2. BACON PA, STEVENS RJ, CARRUTHERS DM et al.: Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 2002; 1: 338-47.
3. GONZALEZ-JUANATEY C, LLORCA J, TESTA A et al.: Increased prevalence of severe sub-clinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003; 82: 407-13.
4. NAGATA-SAKURAI M, INABA M, GOTO H et al.: Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 3061-7.
5. KHOVIDHUNKIT W, KIM MS, MEMON RA et al.: Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequence to the host. J Lip Res 2004; 45: 1169-96.
6. HYKA N, DAYER J-M, MODOUX C et al.: Apolipoprotein (APO)-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 2001; 97: 2381-9.
7. GAZI IF, BOUMPAS DT, MIKHAILIDIS DP et al.: Clustering of cardiovascular risk factors in rheumatoid arthritis: The rationale for using statins. Clin Exp Rheumatol 2007; 25: 102-11.
8. PRETE PE, GURAKAR-OSBORNE A, KASHYAP ML: Synovial fluid lipids and apolipoproteins: A contemporary perspective. Biorheology 1995; 32: 1-16.
9. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
10. MOLL JM, WRIGHT V: Psoriatic arthritis. Semin Arthritis Rheum 1973; 33: 55-78.
11. ALTMAN R, ASCH E, BLOCH D et al.: Development of criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
12. PREVOO ML, VAN 'T HOF MA, KUPER HH et al.: Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
13. HAHN BH, GROSSMAN J, CHEN W et al.: The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia. J Autoimmun 2007; 28: 69-75.
14. DEL RINCON I, WILLIAMS K, STERN MP et al.: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
15. WALLBERG-JONSSON S, BACKMAN C, JOHNSON O et al.: Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: 2597-602.
16. BRESNIHAN B, GOGARTY M, FITZGERALD O, DAYER JM, BURGER D: Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: A control mechanism of cytokine production? Arthritis Res Ther 2004; 6: R563-6.
17. GABAY C, KUSHNER I: Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
18. PUNZI L, OLIVIERO F, PLEBANI M: New biochemical insights in the pathogenesis of osteoarthritis and role of laboratory investigations in clinical assessment. Crit Rev Lab Science 2005; 42: 279-309.
19. HARDARDOTTIR I, MOSER AH, MEMON R et al.: Effects of IL-1 and TNF, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res 1994; 13: 161-6.
20. BURGER D, DAYER J-M: High-density lipoprotein-associated apolipoprotein A-I: The missing link between infection and chronic inflammation? Autoimmunity Rev 2002; 1: 111-7.
21. ANANTH L, PRETE PE, KASHYAP ML: Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis. Metabolism 1993; 42: 803-6.
22. JONES SM, HARRIS CP, LLOYD J et al.: Lipoproteins and their subfractions in psoriatic arthritis: Identification of an atherogenic profile with active joint disease. Ann Rheum Dis 2000; 59: 904-9.